Dr. Lal Pathlabs gets nod to acquire entire stake in Suburban Diagnostics

27 Oct 2021 Evaluate

Dr. Lal Pathlabs has received approval to acquire 100% stake in Suburban Diagnostics (India) from its existing shareholders. The objective of acquisition is to strengthen the Company’s presence in the western part of the country / State of Maharashtra. The board of directors at its meeting held on October 26, 2021 has approved the same.

Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.

Dr. Lal Pathlabs Share Price

2934.60 -18.75 (-0.63%)
23-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7270.35
Max Healthcare Inst 1140.55
Narayana Hrudayalay 1307.35
Aster DM Healthcare 503.45
Global Health 1098.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.